1. An Institutional Experience of a Tertiary Referral Center in Surgically Managing Patients With Gorlin Syndrome.
- Author
-
Dany M, Walker J, Miller CJ, and Giordano CN
- Subjects
- Humans, Quality of Life, Tertiary Care Centers, Mohs Surgery, Basal Cell Nevus Syndrome surgery, Basal Cell Nevus Syndrome pathology, Surgeons, Carcinoma, Basal Cell surgery, Carcinoma, Basal Cell pathology, Skin Neoplasms surgery, Skin Neoplasms pathology
- Abstract
Background: The lifetime risk for basal carcinoma (BCC) is 90% in patients with Gorlin syndrome, also known as basal cell nevus syndrome. Compared with non-Gorlin patients, Gorlin patients often develop BCCs at a younger age and in greater numbers up to 500 BCCs in a lifetime., Objective: To review the options available for Gorlin patients and highlight existing knowledge gaps where future studies are indicated to optimize the care of this unique population., Methods: We review the current literature on managing patients with Gorlin syndrome from the lens of a dermatologic surgeon., Results: Although Mohs surgery is still the gold standard for large and aggressive BCCs, other less-invasive approaches may be considered for smaller, more numerous lesions. As dermatologic surgeons, we must be open to the full spectrum of surgical and nonsurgical options to individualize treatment and optimize patients' quality of life. Without maintaining a balance between optimal cure rate and volume management, Gorlin patients become at risk for surgical burn out and loss to follow-up., Conclusion: Gorlin patients undergo numerous surgeries especially on the central face which can lead to disfigurement and reduce the quality of life. Identifying gaps in the current literature, continuing ongoing research, and eventually establishing appropriate guidelines that help to guide the formation of an individualized treatment plan is crucial in developing a balance between conservative and complex treatments for this population., (Copyright © 2023 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF